Sintesis Analog 3-0-Benzylstentorin sebagai Prekursor untuk Kerangka Dasar Blepharismin
Kata Kunci:
blepharismin, 3-0-benzilstentorin, sintesis, dimerisasi, turunan antrakuinonAbstrak
Metode sintesis prekursor untuk kerangka dasar dan struktural analog blepharismin telah dijelaskan. Senyawa tersebut diidentifikasi sebagai obat yang potensial untuk pengobatan terapi antivirus dan photodynamic. Analog benzil stentorin sebagai kerangka dasar blepharismin secara efektif disintesis melalui reaksi antara salah satu gugus hidroksil senyawa biantrakuinon dengan p-metoksi benzyl klorida dengan adanya kalium karbonat sebagai basa. Dimerisasi senyawa turunan bromo antrakuinon menghasilkan produk dimmer sebesar 55% sedangkan untuk pembentukan senyawa analog 3-0-benzylstentorin diperoleh rendemen hasil 70%.
Referensi
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















